{"database": "lobbying", "table": "lobbying_activities", "rows": [[1441164, "9d42e9d4-f49e-40d7-9b8f-49a8eb4c377d", "Q3", "CHAMBER HILL STRATEGIES", 400645947, "GLAXOSMITHKLINE, INC.", 2013, "third_quarter", "MMM", "Education and importance of various pharmaceutical industry issues, including the Part D prescription drug program", "SENATE", 40000, null, 0, 0, "2013-10-11T15:08:58.257000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1441164"], "units": {}, "query_ms": 43.04273391608149, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}